Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2643)
All Articles published online
|
Aug 28, 2005 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fan JG, Xu ZJ, Wang GL. Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model. World J Gastroenterol 2005; 11(32): 5053-5056 [PMID: 16124065 DOI: 10.3748/wjg.v11.i32.5053] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i32/5053.htm |
| Number | Citing Articles |
| 1 |
Jacquelyn J. Maher. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; : 71 doi: 10.1007/978-3-319-20538-0_4
|
| 2 |
Ze-Hua Zhao, Zi-Xuan Wang, Da Zhou, Yamei Han, Fengguang Ma, Zhimin Hu, Feng-Zhi Xin, Xiao-Lin Liu, Tian-Yi Ren, Feifei Zhang, Yaqian Xue, Aoyuan Cui, Zhengshuai Liu, Jinyun Bai, Yuxiao Liu, Genxiang Cai, Weitong Su, Xiaozhen Dai, Feng Shen, Qin Pan, Yu Li, Jian-Gao Fan. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(3): 857 doi: 10.1016/j.jcmgh.2021.05.006
|
| 3 |
Rajib Mukherjee, Jong Won Yun. Pharmacological inhibition of galectin-1 by lactulose alleviates weight gain in diet-induced obese rats. Life Sciences 2016; 148: 112 doi: 10.1016/j.lfs.2016.02.018
|
| 4 |
A. Federico, M. Trappoliere, C. Loguercio. Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives. Digestive and Liver Disease 2006; 38(11): 789 doi: 10.1016/j.dld.2006.04.009
|
| 5 |
Abdurrahman Kadayifci, Raphael B. Merriman, Nathan M. Bass. Medical Treatment of Non-alcoholic Steatohepatitis. Clinics in Liver Disease 2007; 11(1): 119 doi: 10.1016/j.cld.2007.02.001
|
| 6 |
Jie Yang, Qing-He Nie, An-Hui Wang, Xiao-Feng Huang, Qing-Quan Liu, Yun-Ming Li. Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivo. European Journal of Gastroenterology & Hepatology 2010; 22(11): 1316 doi: 10.1097/MEG.0b013e32833ccaae
|
| 7 |
Teresa C. Delgado, Javier de las Heras, María L. Martínez-Chantar. Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1058101
|
| 8 |
Wan-Chun Wu, Wei Zhao, Sheng Li. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World Journal of Gastroenterology 2008; 14(2): 313-317 doi: 10.3748/wjg.14.313
|
| 9 |
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
|
| 10 |
Ziheng Wei, Yurun Xue, Yucong Xue, Jie Cheng, Guoping Lv, Li Chu, Zhihong Ma, Shengjiang Guan. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. Journal of Pharmacological Sciences 2021; 147(1): 72 doi: 10.1016/j.jphs.2021.05.006
|
| 11 |
Ding‐You Li, Min Yang, Sarah Edwards, Shui‐Qing Ye. Nonalcoholic Fatty Liver Disease. Journal of Parenteral and Enteral Nutrition 2013; 37(6): 787 doi: 10.1177/0148607113481623
|
| 12 |
Mariana V. Machado, Helena Cortez-Pinto. Gut microbiota and nonalcoholic fatty liver disease. Annals of Hepatology 2012; 11(4): 440 doi: 10.1016/S1665-2681(19)31457-7
|
| 13 |
Min Yang, Sitang Gong, Shui Ye, Beth Lyman, Lanlan Geng, Peiyu Chen, Ding-You Li. Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions. Nutrients 2014; 6(11): 4691 doi: 10.3390/nu6114691
|
| 14 |
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8. Digestive Diseases and Sciences 2011; 56(5): 1524 doi: 10.1007/s10620-010-1447-3
|
| 15 |
Ze-Hua Zhao, Feng-Zhi Xin, Yaqian Xue, Zhimin Hu, Yamei Han, Fengguang Ma, Da Zhou, Xiao-Lin Liu, Aoyuan Cui, Zhengshuai Liu, Yuxiao Liu, Jing Gao, Qin Pan, Yu Li, Jian-Gao Fan. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Experimental & Molecular Medicine 2019; 51(9): 1 doi: 10.1038/s12276-019-0304-5
|
| 16 |
Jing Liu, Dakai Yang, Xiaojing Wang, Paul Tetteh Asare, Qingwen Zhang, Lixin Na, Lei Shao. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.774335
|
| 17 |
Gil Weitzman, Neil J. Schamberg, Gerond Lake-Bakaar. Synergism Between Hepatocellular Injury and Shunting in Portosystemic Encephalopathy (PSE): Case Report of Acute Brittle TIPS-Induced PSE. Digestive Diseases and Sciences 2007; 52(11): 3270 doi: 10.1007/s10620-006-9371-2
|
| 18 |
Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway. International Immunopharmacology 2016; 38: 377 doi: 10.1016/j.intimp.2016.06.023
|
| 19 |
Chencheng Xie, Dina Halegoua-DeMarzio. The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 420 doi: 10.1007/s11901-020-00547-5
|
| 20 |
Yao-Xing Huang, Wei-Dong Li, Lin Jia, Jia-Hua Qiu, Shu-Man Jiang, Ya Ou, Hong Du. Infliximab Enhances the Therapeutic Effectiveness of Octreotide on Acute Necrotizing Pancreatitis in Rat Model. Pancreas 2012; 41(6): 849 doi: 10.1097/MPA.0b013e31823fbdc3
|
| 21 |
Al Shaima G. Abd El Salam, Nesma A. Abd Elrazik. Cinnamaldehyde/lactulose combination therapy alleviates thioacetamide-induced hepatic encephalopathy via targeting P2X7R-mediated NLRP3 inflammasome signaling. Life Sciences 2024; 344: 122559 doi: 10.1016/j.lfs.2024.122559
|
| 22 |
Kento Imajo, Masato Yoneda, Takaomi Kessoku, Yuji Ogawa, Shin Maeda, Yoshio Sumida, Hideyuki Hyogo, Yuichiro Eguchi, Koichiro Wada, Atsushi Nakajima. Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2013; 14(11): 21833 doi: 10.3390/ijms141121833
|
| 23 |
Fouad M. F. Elshaghabee, Wilhelm Bockelmann, Diana Meske, Michael de Vrese, Hans-Georg Walte, Juergen Schrezenmeir, Knut J. Heller. Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.00047
|
| 24 |
Ying Zhang, Danni Xiang, Xiaona Hu, Qingwei Ruan, Lina Wang, Zhijun Bao. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. Annals of Hepatology 2020; 19(3): 302 doi: 10.1016/j.aohep.2019.12.003
|
| 25 |
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, Alessia Pascale, Andrea Ferrigno, Annalisa Barbieri. Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention. Cells 2022; 11(18): 2827 doi: 10.3390/cells11182827
|
| 26 |
Youngsung Kim, Jin Woong Kim, Bup Kyung Choi, Nitish Katoch, Eun Ju Yoon, Jong Seon Kim, Young Hoe Hur, Sang Gook Song, Hyung Joong Kim. Evaluation of the Possible Ameliorative Effects of Anemarrhena asphodeloides Extract on Liver Cirrhosis by Combining Biochemical Analysis and Electrical Tissue Conductivity. Applied Sciences 2023; 13(13): 7950 doi: 10.3390/app13137950
|
| 27 |
David Houghton, Christopher Stewart, Christopher Day, Michael Trenell. Gut Microbiota and Lifestyle Interventions in NAFLD. International Journal of Molecular Sciences 2016; 17(4): 447 doi: 10.3390/ijms17040447
|
| 28 |
Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. Frontiers of Medicine 2018; 12(6): 645 doi: 10.1007/s11684-018-0645-9
|
| 29 |
Valentina Castillo, Fernanda Figueroa, Karoll González-Pizarro, Paz Jopia, Claudia Ibacache-Quiroga. Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. Foods 2021; 10(8): 1719 doi: 10.3390/foods10081719
|
| 30 |
Dipali Sharma, Neeraj K. Saxena. Murine Models, Energy Balance, and Cancer. Energy Balance and Cancer 2015; 10: 247 doi: 10.1007/978-3-319-16733-6_12
|
| 31 |
Zheng-Jie Xu, Jian-Gao Fan, Xiao-Dong Ding, Liang Qiao, Guo-Liang Wang. Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats. Digestive Diseases and Sciences 2010; 55(4): 931 doi: 10.1007/s10620-009-0815-3
|
| 32 |
Ahmed Abu-Shanab, Eamonn M. M. Quigley. The role of the gut microbiota in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2010; 7(12): 691 doi: 10.1038/nrgastro.2010.172
|
| 33 |
Jill A. Parnell, Maitreyi Raman, Kevin P. Rioux, Raylene A. Reimer. The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance. Liver International 2012; 32(5): 701 doi: 10.1111/j.1478-3231.2011.02730.x
|
| 34 |
Grace Hatton, Tommaso Alterio, Valerio Nobili, Jake P. Mann. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?. Expert Review of Gastroenterology & Hepatology 2018; 12(10): 961 doi: 10.1080/17474124.2018.1512853
|
| 35 |
Hamed Ebrahimzadeh Leylabadlo, Reza Ghotaslou, Hossein Samadi Kafil, Mohammad Mehdi Feizabadi, Seyed Yaghoub Moaddab, Safar Farajnia, Elham Sheykhsaran, Sarvin Sanaie, Dariush Shanehbandi, Hossein Bannazadeh Baghi. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4): 613 doi: 10.1007/s10096-019-03746-1
|
| 36 |
Lijun Wang, Yu-Jui Yvonne Wan. The role of gut microbiota in liver disease development and treatment. Liver Research 2019; 3(1): 3 doi: 10.1016/j.livres.2019.02.001
|